Want to see TLX full AI Analyst Report?

Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Revenue

5 Followers

Telix Pharmaceuticals Limited Unsponsored ADR Revenue

Telix Pharmaceuticals Limited Unsponsored ADR had a revenue of 691.36M in the quarter ending Jun 30, 2026, with 11.43%. This bring the company's revenue in the last twelve months to 1.31B, Decreased 8.10%. In the fiscal year ending Dec 31, 2025, Telix Pharmaceuticals Limited Unsponsored ADR had annual revenue of 1.21B with 53.91% growth.

Revenue (ttm)

1.31B

Revenue Growth

33.78%

P/S Ratio

3.16

Revenue/Employee

$1,046,377

Employees

1,152

Market Cap

$3.81B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.21B	422.22M	+53.91%
Dec 31, 2024	783.21M	280.66M	+55.85%
Dec 31, 2023	502.55M	342.45M	+213.90%
Dec 31, 2022	160.10M	152.50M	+2,007.64%
Dec 31, 2021	7.60M	2.38M	+45.71%
Dec 31, 2020	5.21M	1.73M	+49.58%
Dec 31, 2019	3.48M	3.29M	+1,685.88%
Dec 31, 2018	195.14K	―	+∞%
Dec 31, 2017	―	―	―